InsidersTradesSigma
Kiniksa Pharmaceuticals, Ltd.: directors' dealings · United States · SEC (Form 4)
SEC:kiniksa-pharmaceuticals-ltd-5de949US·SEC (Form 4)Mcap 4.2Bn€Healthcare
Explore the full directors' dealings record of Kiniksa Pharmaceuticals, Ltd., a publicly traded company based in United States. Shares trade on US US, under the oversight of SEC (Form 4). Operating in the Healthcare sector, Kiniksa Pharmaceuticals, Ltd. has published 14 reports. Market capitalisation: €4.2bn. The latest transaction was reported on 30 June 2022 — Attribution. Among the most active insiders: Ragosa Mark. The full history is openly available.
14
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
54.66 €
Analyst consensus
8 analystsStrong buy
57.00 €Target 63.50 €(+16%)72.00 €
Income statement
Revenue677.6 M€
Gross profit370.3 M€55% margin
Net income59.0 M€9.7% margin
Valuation
PER (trailing)60.1x
PER (forward)31.1x
P/Book7.3x
Beta0.17
Balance sheet & cash
Market cap4.21 Bn€
Total debt9.5 M€
Free Cash Flow136.4 M€
Debt / Equity1%
Profitability & ownership
ROE13.7%
ROA8.2%
% insiders3.6%
% institutions100.7%
Last declaration on 30 June 2022
Declarations0 total
No declarations found
0 of 0 declarations